Jounce Therapeutics
JNCE
#9239
Rank
$0.10 B
Marketcap
$1.88
Share price
0.00%
Change (1 day)
-45.03%
Change (1 year)

Earnings for Jounce Therapeutics (JNCE)

Earnings in 2022 (TTM): -$52.25 Million USD

According to Jounce Therapeutics 's latest financial reports the company's current earnings are $82 Million USD. In 2021 the company made an earning of -$91.06 Million USD a decrease over its 2020 earnings that were of -$45.12 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jounce Therapeutics from 2016 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -$52.25 Million-42.63%
2021 -$91.06 Million101.82%
2020 -$45.12 Million-185.42%
2019 $52.81 M-268.78%
2018 -$31.3 Million62.86%
2017 -$19.22 Million32.83%
2016 -$14.47 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-$0.15 Billion 183.34%๐Ÿ‡บ๐Ÿ‡ธ USA